Primary Cytoreductive Surgery Versus Interval Debulking Surgery Following Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer: An Institutional Review

被引：0
|
作者：
Zeeshanuddin Ahmad
Amar Jain
Nikhil Mehta
Elroy Saldanha
Dhruv Patel
Sanjay M. Desai
机构：
[1] Sri Aurobindo Medical College and Post Graduate Institute,Department of Surgical Oncology
来源：
Indian Journal of Gynecologic Oncology | 2019年 / 17卷
关键词：
Epithelial ovarian cancer (EOC); Primary cytoreductive surgery (PCS); Interval debulking surgery (IDS); Neoadjuvant chemotherapy (NACT);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Primary Cytoreductive Surgery Versus Interval Debulking Surgery Following Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer: An Institutional Review
    Ahmad, Zeeshanuddin
    Jain, Amar
    Mehta, Nikhil
    Saldanha, Elroy
    Patel, Dhruv
    Desai, Sanjay M.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 17 (01)
  • [2] PRIMARY DEBULKING SURGERY OR NEOADJUVANT CHEMOTHERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY FOR PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER?
    Mansouri, H.
    Zemni, I.
    Ben Safta, I.
    Achouri, L.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A120 - A120
  • [3] Neoadjuvant chemotherapy followed by interval debulking surgery versus primary debulking surgery in the advanced epithelial ovarian cancer - a retrospective cohort study
    Maricic, Slobodan
    Mandic, Aljosa
    Dejanovic, Ninoslav
    Kladar, Nebojsa
    Popovic, Marina
    Ivkovic-Kapicl, Tatjana
    Gutic, Bojana
    Kokanov, Dunja
    VOJNOSANITETSKI PREGLED, 2021, 78 (11) : 1193 - 1199
  • [4] Neoadjuvant chemotherapy with interval debulking surgery versus chemotherapy alone for advanced epithelial ovarian cancer
    Khouri, Olivia
    Fazzari, Melissa
    Katcher, Arielle
    Nevadunsky, Nicole
    Fife, Alexander
    Isani, Sara
    Smotkin, David
    Kuo, Dennis Yi-Shin
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S209 - S210
  • [5] Factors that predict optimal debulking at interval cytoreductive surgery after neoadjuvant chemotherapy in epithelial ovarian cancer
    Boccaccio, R. B.
    Crim, A. K.
    Osborn, K.
    Ding, K.
    Moore, K. N.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 82 - 82
  • [6] Primary debulking surgery versus neoadjuvant chemotherapy in elderly patients with epithelial ovarian cancer
    Xu, Z.
    Justiniano, C. F.
    Fleming, F. J.
    Boscoe, F. P.
    Schymura, M. J.
    Rubinsak, L. A.
    Morrow, G.
    Minasian, L.
    Temkin, S. M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 78 - 78
  • [7] Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer
    Vergote, Ignace
    Amant, Frederic
    Kristensen, Gunnar
    Ehlen, Tom
    Reed, Nick S.
    Casado, Antonio
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S88 - S92
  • [8] Primary debulking surgery or neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Zheng, Hong
    Gao, Yu-Nong
    CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (04) : 304 - 309
  • [9] Primary debulking surgery or neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Hong Zheng
    Yu-Nong Gao
    ChineseJournalofCancerResearch, 2012, 24 (04) : 304 - 309
  • [10] PRIMARY DEBULKING SURGERY (PDS) VERSUS NEOADJUVANT CHEMOTHERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY (IDS) FOR PATIENTS WITH ADVANCED OVARIAN CANCER
    Obeidat, R.
    Saidi, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
12345